Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine

NCT00999206 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3138

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Vaccine
BIOLOGICAL: Influenza Vaccine
BIOLOGICAL: Influenza Vaccine
BIOLOGICAL: Influenza Vaccine

Sponsor

Abbott Biologicals

Collaborators

[object Object]